

Virtual Oncology
Apr 10, 2020
Bobby Green, a community oncologist and chief medical officer at Flatiron Health, and Sumit Shah, head of digital health at Stanford Cancer Center, dive into the impact of COVID-19 on oncology. They discuss the shift to virtual care and how patients are balancing risks with treatment needs. Twitter's role in real-time medical insights is highlighted, alongside the surge of virtual clinics. Challenges of telemedicine, patient technology struggles, and the FDA's adaptability in clinical trials reveal how technology is reshaping cancer care in these trying times.
AI Snips
Chapters
Transcript
Episode notes
Patient Empathy
- A patient empathized with others' fear of COVID, comparing it to chemotherapy.
- They understood the fear of vulnerability to infection, demonstrating resilience.
Resilience in Cancer Patients
- Cancer patients show surprising resilience during the pandemic.
- Their prior experience with uncertainty and health crises might contribute to this.
COVID-19's Impact on Treatment Decisions
- Cancer treatment decisions involve weighing risks and benefits.
- COVID-19 introduces new risks, like exposure during clinic visits and hospital overload.